Background The incidence of atopic disease has increased dramatically during recent decades and the potential immunoregulatory influence of the microbiota in these individuals is under investigation.

Objective The aim of our study was to identify a bacterial strain that is protective in murine allergy models and to determine if microbial induction of T regulatory cells was associated with protection from allergic inflammation.

Methods Three microbes (Bifidobacterium breve AH1205, B. longum AH1206 and Lactobacillus salivarius AH102) of human origin were fed to newborn, adult and germ-free animals. Induction of Foxp3⁺ T regulatory cells was assessed by flow cytometry. Gene array analysis was performed on Peyer's patches. Strains were also examined for their protective effects in the ovalbumin (OVA) respiratory allergy model and the OVA-cholera toxin dietary allergy model.

Results Bifidobacterium longum AH1206 consumption resulted in increased numbers of Foxp3⁺ T regulatory cells in infant, adult and germ-free animals. B. breve AH1205 induced Foxp3⁺ T regulatory cell expansion only in infant mice while L. salivarius AH102 did not alter T regulatory cell numbers in any animal model tested. B. longum AH1206 reduced the Peyer's patch gene expression associated with antigen presentation, TLR signalling and cytokine production while increasing the expression of genes associated with retinoic acid metabolism. B. longum AH1206 protected against airway inflammation in OVA-sensitized animals and B. longum AH1206 blocked the induction of IgE to orally administered OVA. Neither B. breve AH1205 nor L. salivarius AH102 had a protective effect in either model.

Conclusion Bacterial strain-specific induction of Foxp3⁺ T regulatory cells in vivo is associated with protection from respiratory and oral allergy.

Cite this as: A. Lyons, D. O'Mahony, F. O'Brien, J. MacSharry, B. Sheil, M. Ceddia, W. M.Russell, P. ForsytheJ. Bienenstock, B. Kiely, F. Shanahan and L. O'Mahony, Clinical & Experimental Allergy, 2010 (40) 811–819.

References

1 Kay AB. Allergy and allergic diseases. N Engl J Med 2001; 344: 30–7.
10.1056/NEJM200101043440106
CAS PubMed Web of Science® Google Scholar
2 Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259–60.
10.1136/bmj.299.6710.1259
CAS PubMed Web of Science® Google Scholar
3 Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004; 112: 352–63.
CAS PubMed Web of Science® Google Scholar
4 Akdis M, Akdis CA. Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov 2009; 8: 645–60.
10.1038/nrd2653
CAS PubMed Web of Science® Google Scholar
5 O'Mahony L, Feeney M, O'Halloran S et al. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Alim Pharmacol Ther 2001; 15: 1219–25.
10.1046/j.1365-2036.2001.01027.x
CAS PubMed Web of Science® Google Scholar
6 McCarthy J, O'Mahony L, O'Callaghan L et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003; 52: 975–80.
10.1136/gut.52.7.975
CAS PubMed Web of Science® Google Scholar
7 O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 541–51.
PubMed Web of Science® Google Scholar
8 Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 2007; 175: 561–9.
10.1164/rccm.200606-821OC
PubMed Web of Science® Google Scholar
9 Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869–71.
PubMed Web of Science® Google Scholar
10 Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076–9.
PubMed Web of Science® Google Scholar
11 Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005; 90: 892–7.
PubMed Web of Science® Google Scholar
12 Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo controlled double-blind study. Allergy 2002; 57: 243–6.
PubMed Web of Science® Google Scholar
13 Karim M, Kingsley CI, Bushell AR, Sawitzki BS, Wood KJ. Alloantigen-induced CD25⁺ CD4⁺ regulatory T cells can develop in vivo from CD25⁻ CD4⁺ precursors in a thymus-independent process. J Immunol 2004; 172: 923–8.
10.4049/jimmunol.172.2.923
CAS PubMed Web of Science® Google Scholar
14 Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4⁺ CD25⁻ naive T cells to CD4⁺ CD25⁺ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875–86.
10.1084/jem.20030152
CAS PubMed Web of Science® Google Scholar
15 Sun CM, Hall JA, Blank RB et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204: 1775–85.
10.1084/jem.20070602
CAS PubMed Web of Science® Google Scholar
16 Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV et al. A functionally specialized population of mucosal CD103⁺ DCs induces Foxp3⁺ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007; 204: 1757–64.
10.1084/jem.20070590
CAS PubMed Web of Science® Google Scholar
17 Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β bearing regulatory cells. J Immunol 2005; 174: 3237–46.
10.4049/jimmunol.174.6.3237
CAS PubMed Web of Science® Google Scholar
18 O'Mahony C, Scully P, O'Mahony D et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-κB activation. PLoS Pathogens 2008; 4: e1000112.
10.1371/journal.ppat.1000112
CAS PubMed Web of Science® Google Scholar
19 Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 2009; 179: 186–93.
10.1164/rccm.200806-951OC
CAS PubMed Web of Science® Google Scholar
20 Murphy C, Murphy S, O'Brien F et al. Metabolic activity of probiotics-oxalate degradation. Vet Microbiol 2009; 136: 100–7.
10.1016/j.vetmic.2008.10.005
CAS PubMed Web of Science® Google Scholar
21 Nagaishi T, Chen Z, Chen L, Iijima H, Nakajima A, Blumberg RS. CEACAM1 and the regulation of mucosal inflammation. Mucosal Immunol 2008; 1 (Suppl. 1): S39–42.
10.1038/mi.2008.50
CAS PubMed Web of Science® Google Scholar
22 Brigelius-Flohé R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 2006; 387: 1329–35.
10.1515/BC.2006.166
CAS PubMed Web of Science® Google Scholar
23 Yamamoto M, Takeda K. Role of nuclear IkappaB proteins in the regulation of host immune responses. J Infect Chemother 2008; 14: 265–9.
10.1007/s10156-008-0619-Y
CAS PubMed Google Scholar
24 Kojima R, Randall JD, Ito E, Manshio H, Suzuki Y, Gullans SR. Regulation of expression of the stress response gene, Osp94: identification of the tonicity response element and intracellular signalling pathways. Biochem J 2004; 380: 783–94.
CAS PubMed Web of Science® Google Scholar
25 Mukherjee S, Partch CL, Lehotzky RE et al. Regulation of C-type lectin antimicrobial activity by a flexible N-terminal prosegment. J Biol Chem 2009; 284: 4881–8.
10.1074/jbc.M808077200
CAS PubMed Web of Science® Google Scholar
26 Miyanaka Y, Ueno Y, Tanaka S et al. Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis. World J Gastroenterol 2007; 13: 2939–44.
10.3748/wjg.v13.i21.2939
CAS PubMed Web of Science® Google Scholar
27 Kanamori M, Suzuki H, Saito R, Muramatsu M, Hayashizaki Y. T2BP, a novel TRAF2 binding protein, can activate NF-kappaB and AP-1 without TNF stimulation. Biochem Biophys Res Commun 2002; 290: 1108–13.
10.1006/bbrc.2001.6315
CAS PubMed Web of Science® Google Scholar
28 Straus DS, Glass CK. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 2007; 28: 551–8.
CAS PubMed Web of Science® Google Scholar
29 Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci 1998; 81: 48–53.
10.3168/jds.S0022-0302(98)75549-3
CAS PubMed Web of Science® Google Scholar
30 Zuany-Amorim C, Sawicka E, Manlius C et al. Suppression of airway eosinophilia by killed mycobacterium vaccae induced allergen-specific regulatory T-cells. Nat Med 2002; 8: 625–9.
10.1038/nm0602-625
Google Scholar
31 Leech MD, Benson RA, De Vries A, Fitch PM, Howie SE. Resolution of Der p1-induced allergic airway inflammation is dependent on CD4⁺ CD25⁺ Foxp3⁺ regulatory cells. J Immunol 2007; 179: 7050–8.
10.4049/jimmunol.179.10.7050
Google Scholar
32 McGlade JP, Gorman S, Zosky GR et al. Suppression of the asthmatic phenotype by ultraviolet b-induced, antigen-specific regulatory cells. Clin Exp Allergy 2007; 37: 1267–76.
10.1111/j.1365-2222.2007.02750.x
CAS PubMed Web of Science® Google Scholar
33 Strickland DH, Stumbles PA, Zosky GR et al. Reversal of airway hyperresponsiveness by induction of airway mucosal CD4⁺ CD25⁺ regulatory Tcells. J Exp Med 2006; 203: 2649–60.
10.1084/jem.20060155
CAS PubMed Web of Science® Google Scholar
34 Wu K, Bi Y, Sun K, Xia J, Wang Y, Wang C. Suppression of allergic inflammation by allergen-DNA-modified dendritic cells depends on the induction of Foxp3⁺ regulatory T cells. Scand J Immunol 2008; 67: 140–51.
10.1111/j.1365-3083.2007.02050.x
CAS PubMed Web of Science® Google Scholar
35 Boudousquié C, Pellaton C, Barbier N, Spertini F. CD4⁺ CD25⁺ T cell depletion impairs tolerance induction in a murine model of asthma. Clin Exp Allergy 2009; 39: 1415–26.
10.1111/j.1365-2222.2009.03314.x
CAS PubMed Web of Science® Google Scholar
36 Larché M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6: 761–71.
10.1038/nri1934
CAS PubMed Web of Science® Google Scholar
37 Meiler F, Zumkehr J, Klunker S, Rückert B, Akdis CA, Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008; 205: 2887–98.
10.1084/jem.20080193
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume40, Issue5

May 2010

Pages 811-819

Bacterial strain-specific induction of Foxp3⁺ T regulatory cells is protective in murine allergy models

Summary

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models

Summary

References

Citing Literature

References

Related

Information

Bacterial strain-specific induction of Foxp3⁺ T regulatory cells is protective in murine allergy models